Search Results

Featured Stories

Toggle

Showing 10 of 290 results

Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report

TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today published its 2020 Environmental, Social and Governance (ESG) Progress Report detailing the...

Teva to Present New Data on AJOVY® (fremanezumab-vfrm) Injection Open-Label Extension Study at American H

TEL AVIV & PARSIPPANY, N.J.--( BUSINESS WIRE )-- Teva Pharmaceuticals USA, Inc., an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced 24 abstracts featuring dat...

Teva and Celltrion Healthcare Announce the Launch of TRUXIMA® (rituximab-abbs) Injection for Rheumatoid A

TRUXIMA is also now available for the treatment of Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) Teva Pharmaceuticals USA, Inc., a U.S....

New Data For Teva AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets Included i

23 abstracts appeared in the 2020 American Academy of Neurology (AAN) Science Highlights Supplement Teva Pharmaceuticals USA, Inc., an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TAS...

Teva Announces U.S. Launch of Autoinjector for AJOVY® (fremanezumab-vfrm) Injection

Teva Pharmaceuticals USA, Inc., an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the autoinjector device for AJOVY ® (fremanezumab-vfrm) injection is...

Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide

 Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today t...

Teva Announces Registration Trials of Deutetrabenazine in Pediatric Patients with Tourette Syndrome Did N

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Phase 2/3 ARTISTS 1 and Phase 3 ARTISTS 2 trials designed to evaluate deutetrabenazine compared to placebo for the...